{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:29:25Z","timestamp":1786980565423,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T00:00:00Z","timestamp":1400630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s10157-014-0982-1","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T04:06:30Z","timestamp":1400558790000},"page":"197-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides"],"prefix":"10.1007","volume":"19","author":[{"given":"Fumiki","family":"Yoshihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tokudome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Otani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsunori","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Horio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kangawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,21]]},"reference":[{"key":"982_CR1","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1681\/ASN.V1191691","volume":"11","author":"M Kasahara","year":"2000","unstructured":"Kasahara M, Mukoyama M, Sugawara A, et al. Ameliorated glomerular injury in mice overexpressing brain natriuretic peptide with renal ablation. J Am Soc Nephrol. 2000;11:1691\u2013701.","journal-title":"J Am Soc Nephrol"},{"key":"982_CR2","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1681\/ASN.V12122652","volume":"12","author":"T Suganami","year":"2001","unstructured":"Suganami T, Mukoyama M, Sugawara A, et al. Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury. J Am Soc Nephrol. 2001;12:2652\u201363.","journal-title":"J Am Soc Nephrol"},{"key":"982_CR3","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1007\/s00125-006-0352-y","volume":"49","author":"H Makino","year":"2006","unstructured":"Makino H, Mukoyama M, Mori K, et al. Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice. Diabetologia. 2006;49:2514\u201324.","journal-title":"Diabetologia"},{"key":"982_CR4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jjcc.2010.08.001","volume":"56","author":"Y Saito","year":"2010","unstructured":"Saito Y. Roles of atrial natriuretic peptide and its therapeutic use. J Cardiol. 2010;56:262\u201370.","journal-title":"J Cardiol"},{"key":"982_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/378065a0","volume":"378","author":"MJ Lopez","year":"1995","unstructured":"Lopez MJ, Wong SK, Kishimoto I, et al. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature. 1995;378:65\u20138.","journal-title":"Nature"},{"key":"982_CR6","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1172\/JCI23360","volume":"115","author":"K Sabrane","year":"2005","unstructured":"Sabrane K, Kruse MN, Fabritz L, et al. Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide. J Clin Invest. 2005;115:1666\u201374.","journal-title":"J Clin Invest"},{"key":"982_CR7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/cvr\/cvr279","volume":"93","author":"W Chen","year":"2012","unstructured":"Chen W, Gassner B, B\u00f6rner S, et al. Atrial natriuretic peptide enhances microvascular albumin permeability by the\u00a0caveolae-mediated transcellular pathway. Cardiovasc Res. 2012;93:141\u201351.","journal-title":"Cardiovasc Res"},{"key":"982_CR8","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1681\/ASN.2011100985","volume":"23","author":"Y Ogawa","year":"2012","unstructured":"Ogawa Y, Mukoyama M, Yokoi H, et al. Natriuretic peptide receptor guanylyl cyclase-a protects podocytes from aldosterone-induced glomerular injury. J Am Soc Nephrol. 2012;23:1198\u2013209.","journal-title":"J Am Soc Nephrol"},{"key":"982_CR9","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","volume":"63","author":"ER Blasi","year":"2003","unstructured":"Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, McMahon EG. Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int. 2003;63:1791\u2013800.","journal-title":"Kidney Int"},{"key":"982_CR10","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0002-9440(10)61208-4","volume":"167","author":"JL Faulkner","year":"2005","unstructured":"Faulkner JL, Szcykalski LM, Springer F, Barnes JL. Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis. Am J Pathol. 2005;167:1193\u2013205.","journal-title":"Am J Pathol"},{"key":"982_CR11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/01.HYP.0000013734.33441.EA","volume":"39","author":"H Mitani","year":"2002","unstructured":"Mitani H, Ishizaka N, Aizawa T, et al. In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension. 2002;39:838\u201343.","journal-title":"Hypertension"},{"key":"982_CR12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/01.HYP.19.5.464","volume":"19","author":"RJ Johnson","year":"1992","unstructured":"Johnson RJ, Alpers CE, Yoshimura A, et al. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992;19:464\u201374.","journal-title":"Hypertension"},{"key":"982_CR13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000045886","volume":"87","author":"DM Lombardi","year":"2001","unstructured":"Lombardi DM, Viswanathan M, Vio CP, Saavedra JM, Schwartz SM, Johnson RJ. Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent. Nephron. 2001;87:66\u201374.","journal-title":"Nephron"},{"key":"982_CR14","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.amjhyper.2005.09.022","volume":"19","author":"H Kitayama","year":"2006","unstructured":"Kitayama H, Maeshima Y, Takazawa Y, et al. Regulation of angiogenic factors in\u00a0angiotensin II\u00a0infusion model in association with tubulointerstitial injuries. Am J Hypertens. 2006;19:718\u201327.","journal-title":"Am J Hypertens"},{"key":"982_CR15","doi-asserted-by":"crossref","first-page":"F330","DOI":"10.1152\/ajprenal.00059.2006","volume":"292","author":"Y Ozawa","year":"2007","unstructured":"Ozawa Y, Kobori H, Suzaki Y, Navar LG. Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am J Physiol Renal Physiol. 2007;292:F330\u20139.","journal-title":"Am J Physiol Renal Physiol"},{"key":"982_CR16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ki.1994.67","volume":"45","author":"CM Giachelli","year":"1994","unstructured":"Giachelli CM, Pichler R, Lombardi D, et al. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int. 1994;45:515\u201324.","journal-title":"Kidney Int"},{"key":"982_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(12)80312-X","volume":"20","author":"KA Nath","year":"1995","unstructured":"Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis. 1995;20:1\u201317.","journal-title":"Am J Kidney Dis"},{"key":"982_CR18","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/01.LAB.0000101911.53973.90","volume":"83","author":"A Desmouli\u00e8re","year":"2003","unstructured":"Desmouli\u00e8re A, Darby IA, Gabbiani G. Normal and pathologic soft\u00a0tissue\u00a0remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest. 2003;83:1689\u2013707.","journal-title":"Lab Invest"},{"key":"982_CR19","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1161\/CIRCULATIONAHA.104.510594","volume":"111","author":"T Tokudome","year":"2005","unstructured":"Tokudome T, Horio T, Kishimoto I, et al. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides. Circulation. 2005;111:3095\u2013104.","journal-title":"Circulation"},{"key":"982_CR20","doi-asserted-by":"crossref","first-page":"e40402","DOI":"10.1371\/journal.pone.0040402","volume":"7","author":"A Quesada","year":"2012","unstructured":"Quesada A, Vargas F, Montoro-Molina S, et al. Urinary aminopeptidase activities as early and predictive biomarkers of renal dysfunction in cisplatin-treated rats. PLoS ONE. 2012;7:e40402.","journal-title":"PLoS ONE"},{"key":"982_CR21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1152\/japplphysiol.00468.2006","volume":"102","author":"P Li","year":"2007","unstructured":"Li P, Oparil S, Novak L, et al. ANP signaling inhibits TGF-beta-induced Smad2 and Smad3 nuclear translocation and extracellular matrix expression in rat pulmonary arterial smooth muscle cells. J Appl Physiol. 2007;102:390\u20138.","journal-title":"J Appl Physiol"},{"key":"982_CR22","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1189\/jlb.0603254","volume":"74","author":"NC Weber","year":"2003","unstructured":"Weber NC, Blumenthal SB, Hartung T, Vollmar AM, Kiemer AK. ANP inhibits TNF-alpha-induced endothelial MCP-1 expression\u2013involvement of p38 MAPK and MKP-1. J Leukoc Biol. 2003;74:932\u201341.","journal-title":"J Leukoc Biol"},{"key":"982_CR23","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2353\/ajpath.2007.060484","volume":"170","author":"K Suzuki","year":"2007","unstructured":"Suzuki K, Han GD, Miyauchi N, et al. Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall. Am J Pathol. 2007;170:1841\u201353.","journal-title":"Am J Pathol"},{"issue":"part 2","key":"982_CR24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/01.HYP.35.1.409","volume":"35","author":"O Baltatu","year":"2000","unstructured":"Baltatu O, Silva JA Jr, Ganten D, Bader M. The brain renin-angiotensin system modulates angiotensin II-induced hypertension and cardiac hypertrophy. Hypertension. 2000;35(part 2):409\u201312.","journal-title":"Hypertension"},{"key":"982_CR25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2125.1994.tb04337.x","volume":"38","author":"RI Cargill","year":"1994","unstructured":"Cargill RI, Coutie WJ, Lipworth BJ. The effects of angiotensin II on circulating levels of natriuretic peptides. Br J Clin Pharmacol. 1994;38:139\u201342.","journal-title":"Br J Clin Pharmacol"},{"key":"982_CR26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/324473a0","volume":"324","author":"M Marin-Grez","year":"1986","unstructured":"Marin-Grez M, Fleming JT, Steinhausen M. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature. 1986;324:473\u20136.","journal-title":"Nature"},{"key":"982_CR27","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1681\/ASN.2006040377","volume":"17","author":"M Abbate","year":"2006","unstructured":"Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol. 2006;17:2974\u201384.","journal-title":"J Am Soc Nephrol"},{"key":"982_CR28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1523-1755.2004.00461.x","volume":"65","author":"K Manotham","year":"2004","unstructured":"Manotham K, Tanaka T, Matsumoto M, et al. Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int. 2004;65:871\u201380.","journal-title":"Kidney Int"},{"key":"982_CR29","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/ki.2009.62","volume":"75","author":"S Sun","year":"2009","unstructured":"Sun S, Ning X, Zhang Y, et al. Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int. 2009;75:1278\u201387.","journal-title":"Kidney Int"},{"key":"982_CR30","doi-asserted-by":"crossref","first-page":"F1248","DOI":"10.1152\/ajprenal.00096.2006","volume":"291","author":"DA Long","year":"2006","unstructured":"Long DA, Mu W, Price KL, et al. Vascular endothelial growth factor administration does not improve microvascular disease in the salt-dependent phase of post-angiotensin II hypertension. Am J Physiol Renal Physiol. 2006;291:F1248\u201354.","journal-title":"Am J Physiol Renal Physiol"},{"key":"982_CR31","first-page":"F653","volume":"271","author":"N Parekh","year":"1996","unstructured":"Parekh N, Zou AP. Role\u00a0of\u00a0prostaglandins\u00a0in\u00a0renal\u00a0medullary\u00a0circulation: response to different vasoconstrictors. Am J Physiol. 1996;271:F653\u20138.","journal-title":"Am J Physiol"},{"key":"982_CR32","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/HYPERTENSIONAHA.111.177626","volume":"58","author":"Q Zhu","year":"2011","unstructured":"Zhu Q, Wang Z, Xia M, et al. Silencing of hypoxia-inducible factor-1\u03b1 gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats. Hypertension. 2011;58:657\u201364.","journal-title":"Hypertension"},{"key":"982_CR33","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1161\/ATVBAHA.109.187526","volume":"29","author":"T Tokudome","year":"2009","unstructured":"Tokudome T, Kishimoto I, Yamahara K, et al. Impaired recovery of blood flow after hind-limb ischemia in mice lacking guanylyl cyclase-A, a receptor for atrial and brain natriuretic peptides. Arterioscler Thromb Vasc Biol. 2009;29:1516\u201321.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"982_CR34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1620\/tjem.166.41","volume":"166","author":"PM Sexton","year":"1992","unstructured":"Sexton PM, Zhuo J, Mendelsohn FA. Localization and regulation of renal receptors for angiotensin II and atrial natriuretic peptide. Tohoku J Exp Med. 1992;166:41\u201356.","journal-title":"Tohoku J Exp Med"},{"issue":"part 2","key":"982_CR35","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/01.HYP.0000051890.68573.94","volume":"41","author":"R Garg","year":"2003","unstructured":"Garg R, Pandey KN. Angiotensin II-mediated negative regulation of Npr1 promoter activity and gene transcription. Hypertension. 2003;41(part 2):730\u20136.","journal-title":"Hypertension"},{"key":"982_CR36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbrc.2006.08.003","volume":"349","author":"KK Arise","year":"2006","unstructured":"Arise KK, Pandey KN. Inhibition and down-regulation of gene transcription and guanylyl cyclase activity of NPRA by angiotensin II involving protein kinase C. Biochem Biophys Res Commun. 2006;349:131\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"982_CR37","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s11033-012-2186-7","volume":"40","author":"P Hu","year":"2013","unstructured":"Hu P, Wang J, Zhao XQ, Hu B, Lu L, Qin YH. Overexpressed C-type natriuretic peptide serves as an early compensatory response to counteract extracellular matrix remodeling in unilateral ureteral obstruction rats. Mol Biol Rep. 2013;40:1429\u201341.","journal-title":"Mol Biol Rep"},{"key":"982_CR38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/PL00005140","volume":"357","author":"K Segawa","year":"1998","unstructured":"Segawa K, Minami K, Jimi N, Nakashima Y, Shigematsu A. C-type natriuretic peptide inhibits rat mesangial cell proliferation by a phosphorylation-dependent mechanism. Naunyn Schmiedebergs Arch Pharmacol. 1998;357:70\u20136.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"982_CR39","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1046\/j.1523-1755.1998.00895.x","volume":"53","author":"S Canaan-K\u00fchl","year":"1998","unstructured":"Canaan-K\u00fchl S, Ostendorf T, Zander K, Koch KM, Floege J. C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo. Kidney Int. 1998;53:1143\u201351.","journal-title":"Kidney Int"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-014-0982-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-014-0982-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-014-0982-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T16:55:15Z","timestamp":1649004915000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-014-0982-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,21]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["982"],"URL":"https:\/\/doi.org\/10.1007\/s10157-014-0982-1","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,21]]}}}